CoChat

The Role of MicroRNA-146a in the Pathogenesis of the Diabetic Wound-Healing Impairment

Open access
Xu, Junwang, Wu, Wenjie, Zhang, Liping, Dorset-Martin, Wanda, Morris, Michael W., Mitchell, Marc E., Liechty, Kenneth W. · 2012 · Diabetes

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

The impairment in diabetic wound healing represents a significant clinical problem. Chronic inflammation is thought to play a central role in the pathogenesis of this impairment. We have previously shown that treatment of diabetic murine wounds with mesenchymal stem cells (MSCs) can improve healing, but the mechanisms are not completely defined. MicroRNA-146a (miR-146a) has been implicated in regulation of the immune and inflammatory responses. We hypothesized that abnormal miRNA-146a expression may contribute to the chronic inflammation. To test this hypothesis, we examined the expression of miRNA-146a and its target genes in diabetic and nondiabetic mice at baseline and after injury. MiR-146a expression was significantly downregulated in diabetic mouse wounds. Decreased miR-146a levels also closely correlated with increased gene expression of its proinflammatory target genes. Furthermore, the correction of the diabetic wound-healing impairment with MSC treatment was associated with a significant increase in the miR-146a expression level and decreased gene expression of its proinflammatory target genes. These results provide the first evidence that decreased expression of miR-146a in diabetic wounds in response to injury may, in part, be responsible for the abnormal inflammatory response seen in diabetic wounds and may contribute to wound-healing impairment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db12-0145

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Dynamic expression level changes of miR-146a during the wound-healing process. Real-time quantitative RT-PCR analysis of miR-146a levels in db/+ (n = 5) and db/db (n = 5) wounds at 0, 1, 3, 7, 14, and 21 days after dermal injury. MiR-146a gene expression was calculated after normalizing with U6. #P < 0.01 comparing db/db wounds with db/+ wounds.
FIG. 1. Dynamic expression level changes of miR-146a during the wound-healing process. Real-time quantitative RT-PCR analysis of miR-146a levels in db/+ (n = 5) and db/db (n = 5) wounds at 0, 1, 3, 7, 14, and 21 days after dermal injury. MiR-146a gene expression was calculated after normalizing with U6. #P < 0.01 comparing db/db wounds with db/+ wounds.CC BY-NC-ND · PubMed Central
FIG. 2. Dynamic changes of miR-146a direct targets IRAK1 and TRAF6 during the wound-healing process. A: IRAK1 and TRAF6 mRNA structure and predicted targets of miR-146a by the TargetScan Web site (http://www.targetscan.org/). Real-time quantitative RT-PCR analysis of mRNA for IRAK1 (B) and TRAF6 (C) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at 1, 3, 7, 14, and 21 days after dermal injury. #P < 0.01 comparing db/db wounds with db/+ wounds.
FIG. 2. Dynamic changes of miR-146a direct targets IRAK1 and TRAF6 during the wound-healing process. A: IRAK1 and TRAF6 mRNA structure and predicted targets of miR-146a by the TargetScan Web site (http://www.targetscan.org/). Real-time quantitative RT-PCR analysis of mRNA for IRAK1 (B) and TRAF6 (C) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at 1, 3, 7, 14, and 21 days after dermal injury. #P < 0.01 comparing db/db wounds with db/+ wounds.CC BY-NC-ND · PubMed Central
FIG. 3. Dynamic changes of proinflammatory factors during the wound-healing process. Real-time quantitative RT-PCR analysis of mRNA for NF-κB (A), IL-6 (B), and MIP-2 (C) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at 1, 3, 7, 14, and 21 days after dermal injury. #P < 0.01, *P < 0.05 comparing db/db wounds with db/+ wounds.
FIG. 3. Dynamic changes of proinflammatory factors during the wound-healing process. Real-time quantitative RT-PCR analysis of mRNA for NF-κB (A), IL-6 (B), and MIP-2 (C) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at 1, 3, 7, 14, and 21 days after dermal injury. #P < 0.01, *P < 0.05 comparing db/db wounds with db/+ wounds.CC BY-NC-ND · PubMed Central
FIG. 4. MSC treatment accelerates wound closure and upregulates miR-146a level in diabetic wounds. A: Diabetic wounds at day (D) 7 treated with vehicle (left) and MSCs (right). B: Quantitative analysis of wound closure at day 7 in diabetic wounds treated with vehicle and MSCs (n = 10). C: CD45 immunostaining of sections from nondiabetic (C1, 3) and diabetic wounds (C2, 4) treated with vehicle (top) and MSCs (bottom). D: Fluorescent image demonstrates GFP signal at the wound edge (arrows indicate the injection sites). E: Real-time PCR analysis of miR-146a expression level in db/+ (Hz; n = 5) and db/db (n = 5) wounds at day 7 with MSC or vehicle treatment. *P < 0.05 comparing db/db wounds treated with MSCs with db/db wounds treated with vehicle. (A high-quality digital representation of this figure is available in the online issue.)
FIG. 4. MSC treatment accelerates wound closure and upregulates miR-146a level in diabetic wounds. A: Diabetic wounds at day (D) 7 treated with vehicle (left) and MSCs (right). B: Quantitative analysis of wound closure at day 7 in diabetic wounds treated with vehicle and MSCs (n = 10). C: CD45 immunostaining of sections from nondiabetic (C1, 3) and diabetic wounds (C2, 4) treated with vehicle (top) and MSCs (bottom). D: Fluorescent image demonstrates GFP signal at the wound edge (arrows indicate the injection sites). E: Real-time PCR analysis of miR-146a expression level in db/+ (Hz; n = 5) and db/db (n = 5) wounds at day 7 with MSC or vehicle treatment. *P < 0.05 comparing db/db wounds treated with MSCs with db/db wounds treated with vehicle. (A high-quality digital representation of this figure is available in the online issue.)CC BY-NC-ND · PubMed Central
FIG. 5. MSC treatment downregulates levels of NF-κB, IL-6, and MIP-2 in diabetic wounds. Real-time quantitative RT-PCR analysis of mRNA, IRAK1 (A), TRAF6 (B), NF-κB (C), IL-6 (D), and MIP-2 (E) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at days (D) 3 and 7 after dermal injury with MSCs or vehicle treatment. F: ELISA analysis of wound MIP-2 protein concentration.
FIG. 5. MSC treatment downregulates levels of NF-κB, IL-6, and MIP-2 in diabetic wounds. Real-time quantitative RT-PCR analysis of mRNA, IRAK1 (A), TRAF6 (B), NF-κB (C), IL-6 (D), and MIP-2 (E) in db/+ (Hz; n = 5) and db/db (n = 5) wounds at days (D) 3 and 7 after dermal injury with MSCs or vehicle treatment. F: ELISA analysis of wound MIP-2 protein concentration.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Cited by

Metadata

Authors
Xu, J., Wu, W., Zhang, L., Dorset-Martin, W., Morris, M. W., Mitchell, M. E., & Liechty, K. W.
Affiliations
  • University of Mississippi Medical Center (US)
  • Department of Surgery, University of Mississippi Medical Center, Jackson, Mississippi
Venue
Diabetes
Published
2012-10-16
Volume
61
Issue
11
Pages
2906-2912
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2134161094
Cited by
225
References
38
Citations by year
2026: 9 · 2025: 13 · 2024: 12 · 2023: 23 · 2022: 14 · 2021: 23 · 2020: 26 · 2019: 17 · 2018: 15 · 2017: 15 · 2016: 20 · 2015: 14 · 2014: 17 · 2013: 5 · 2012: 2
FWCI
12.86
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (DP2DK083085)
Topics
  • Health Sciences › Medicine › Surgery › Wound Healing and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords
microRNA-146a, diabetic wound healing, chronic inflammation, mesenchymal stem cells, pro-inflammatory gene expression, diabetic wounds, miRNA target genes, inflammation in diabetes
MeSH terms
Animals, Female, Mice, Mutant Strains, Mice, Transgenic, RNA, Messenger, Skin, Time Factors, Wound Healing, Wounds, Penetrating, Down-Regulation, Up-Regulation, Cytokines, NF-kappa B, Back Injuries, MicroRNAs, Mesenchymal Stem Cell Transplantation, TNF Receptor-Associated Factor 6, Diabetes Complications, Mice, Interleukin-1 Receptor-Associated Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.